Andrew L Campbell Selected Research

Andrew L Campbell Research Topics

3	Infections 03/2015 - 12/2004
2	Fibrosis (Cirrhosis) 03/2015 - 05/2014
2	Hepatitis C 03/2015 - 05/2014
1	Asthma (Bronchial Asthma) 01/2017
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2017
1	Eosinophilic Esophagitis 01/2017
1	Coinfection 03/2015
1	Body Weight (Weight, Body) 05/2014
1	Toxoplasmosis 02/2006
1	Opportunistic Infections (Opportunistic Infection) 12/2004
1	Cytomegalovirus Infections (Inclusion Disease) 12/2004

3	Antiviral Agents (Antivirals)IBA 03/2015 - 12/2004
2	InterferonsIBA 03/2015 - 05/2014
2	dasabuvirIBA 03/2015 - 05/2014
2	Ribavirin (Virazole)FDA LinkGeneric 03/2015 - 05/2014
2	Ritonavir (Norvir)FDA Link 03/2015 - 05/2014
2	paritaprevirIBA 03/2015 - 05/2014
2	ombitasvirIBA 03/2015 - 05/2014
1	cendakimabIBA 01/2017
1	AntibodiesIBA 01/2017
1	Monoclonal AntibodiesIBA 01/2017
1	InterleukinsIBA 01/2017
1	OvalbuminIBA 01/2017
1	Interleukin-13IBA 01/2017
1	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 01/2017
1	RNA (Ribonucleic Acid)IBA 03/2015
1	Raltegravir Potassium FDA Link 03/2015
1	Atazanavir Sulfate (Reyataz)FDA Link 03/2015
1	dimemorfan (AT 17)IBA 03/2015
1	Protease Inhibitors (Protease Inhibitor)IBA 05/2014
1	Immunosuppressive Agents (Immunosuppressants)IBA 12/2004